Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity

被引:0
|
作者
Khamsri, Boonruang
Fujita, Mikako
Kamada, Kazuya
Piroozmand, Ahmad
Yamashita, Tomoki
Uchiyama, Tsuneo
Adachi, Akio
机构
[1] Univ Tokushima, Dept Virol, Inst Hlth Biosci, Grad Sch, Tokushima 7708503, Japan
[2] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok 65000, Thailand
关键词
HIV-1; Vif; lysine; arginine;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We previously demonstrated that the expression in cells of human immunodeficiency virus type 1 (HIV-1) Vif is maintained at low level by proteasome-degradation. We examined the contribution of 16 lysines present in Vif (NL432 clone), which is composed of 192 amino acids (aa), to its expression within cells and to viral infectivity for non-permissive cells. To this end, various lysine-arginine mutations were introduced into wild-type (wt) Vif, and the mutational effects were monitored by transfection experiments. When all the lysines were changed to arginines, the mutant Vif was expressed in cells at much higher level than wt and was much more stable. Both N-terminal (aa nos. 34 and 36) and C-terminal (aa nos. 179 and 181) lysines were found to be almost sufficient for wt property. Different from this observation, one of the lysines at aa nos. 22 and 26 was demonstrated to be essential for the virus to grow in non-permissive cells. Our results showed that there is no clear co-relationship between the expression level of HIV-1 Vif and viral infectivity.
引用
收藏
页码:679 / 683
页数:5
相关论文
共 50 条
  • [31] Host Restriction of HIV-1 by APOBEC3 and Viral Evasion Through Vif
    Niewiadomska, Anna Maria
    Yu, Xiao-Fang
    HIV INTERACTIONS WITH HOST CELL PROTEINS, 2009, 339 : 1 - 25
  • [32] The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral Vif protein
    Hassaïne, G
    Courcoul, M
    Bessou, G
    Barthalay, Y
    Picard, C
    Olive, D
    Collette, Y
    Vigne, R
    Decroly, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) : 16885 - 16893
  • [33] Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits viral replication
    Goncalves, J
    Silva, F
    Freitas-Vieira, A
    Santa-Marta, M
    Malhó, R
    Yang, X
    Gabuzda, D
    Barbas, C
    XIV INTERNATIONAL AIDS CONFERENCE: BASIC SCIENCES, 2002, : 219 - 226
  • [34] Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
    Sheehy, AM
    Gaddis, NC
    Choi, JD
    Malim, MH
    NATURE, 2002, 418 (6898) : 646 - 650
  • [35] Changes in the vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease
    Adekale, MA
    Cane, PA
    McCrae, MA
    JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (02) : 195 - 201
  • [36] EXPRESSION OF THE HIV-1 NEF GENE DURING HIV-1 PRODUCTION INCREASES PROGENY PARTICLE INFECTIVITY INDEPENDENTLY OF GP160 OR VIRAL ENTRY
    MILLER, MD
    WARMERDAM, MT
    PAGE, KA
    FEINBERG, MB
    GREENE, WC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 194 - 194
  • [37] Translational regulation of APOBEC3G mRNA by Vif requires its 5′UTR and contributes to restoring HIV-1 infectivity
    Guerrero, Santiago
    Libre, Camille
    Batisse, Julien
    Mercenne, Gaelle
    Richer, Delphine
    Laumond, Geraldine
    Decoville, Thomas
    Moog, Christiane
    Marquet, Roland
    Paillart, Jean-Christophe
    SCIENTIFIC REPORTS, 2016, 6
  • [38] Translational regulation of APOBEC3G mRNA by Vif requires its 5′UTR and contributes to restoring HIV-1 infectivity
    Santiago Guerrero
    Camille Libre
    Julien Batisse
    Gaëlle Mercenne
    Delphine Richer
    Géraldine Laumond
    Thomas Decoville
    Christiane Moog
    Roland Marquet
    Jean-Christophe Paillart
    Scientific Reports, 6
  • [39] HIV-1 Vif, APOBEC, and Intrinsic Immunity
    Ritu Goila-Gaur
    Klaus Strebel
    Retrovirology, 5
  • [40] HIV-1 concentrates and shelters cell-associated infectivity a "viral biofilm"
    Inizan, C.
    Derames, A.
    Caillet, M.
    David, A.
    Versmisse, P.
    Saez-Cirion, A.
    Mesel-Lemoine, M.
    Mallet, A.
    Sachse, M.
    Mouquet, H.
    Boufassa, F.
    Lambotte, O.
    Bourdic, K.
    Thoulouze, M-I
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 48 - 49